Nabriva Therapeutics Ownership | Who Owns Nabriva Therapeutics?
Nabriva Therapeutics Ownership Summary
100.00% retail investors. AQA Colombo Extra Return B EUR Acc is the top mutual fund, with 0.08% of its assets in Nabriva Therapeutics shares.
NBRV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Nabriva Therapeutics | - | - | 100.00% |
Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2022 | 1 | - | 3,000 | -40.00% | - | 6562.35% | - | - | 1 | - |
Mar 31, 2022 | 1 | - | 5,000 | - | - | 10485.56% | - | - | - | - |
Dec 31, 2021 | 1 | - | 5,000 | - | - | 9197.98% | - | - | - | - |
Sep 30, 2021 | 1 | - | 5,000 | - | - | 6528.46% | - | - | - | - |
Jun 30, 2021 | 1 | - | 5,000 | - | - | 3444.44% | - | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
AQA Colombo Extra Return B EUR Acc | 2.60K | 0.08% | - |
Vifag 2002 SICAV | 600.00 | 0.02% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 02, 2022 | BURGESS DANIEL D | Sell | $2.16K | |
Aug 02, 2022 | Broom Colin MD | Sell | $1.02K | |
Aug 02, 2022 | Webster Stephen W | Sell | $1.49K | |
Aug 02, 2022 | CORRIGAN MARK | Sell | $1.96K | |
Aug 01, 2022 | Rowland Charles A Jr | - | Sell | $1.49K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q1 | - | - |
2022 Q4 | - | - |
2022 Q3 | - | 6 |
2022 Q2 | - | - |
2022 Q1 | - | - |
NBRV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools